Beschreibung
The active substance and international name of the drug Azithromycin:
Azithromycin (Azithromycin)
The manufacturer of the drug Azithromycin:
1) Holden Medical B.V. (Netherlands) and Holden Medical Laboratories Pvt. GmbH (India), packaged and packaged JV arable land (RB)
2) by Borisov Medical preparations Plant (Belarus)
Azithromycin release form of the drug:
1) tablets, film-coated 250 mg polymer in the banks in a package No6 No1
2) tablets, film-coated 500 mg polymer in banks No2, No3 and No6 in package No1
3) 250 mg capsules in bubbles and No6 bank No6 compartment No1
The pharmacological effect of the drug Azithromycin:
Azithromycin is a drug from the group of azalids. The mechanism of antibacterial action of azithromycin drug due to its ability to inhibit bacterial synthesis by binding proteins with 50S ribosomal subunit and inhibits phase peptide translocation. Azithromycin possesses broad spectrum antimicrobial activity against Gram-positive and Gram-negative, intracellular, and other microorganisms. In particular, the drug is effective against aerobic Gram-positive and Gram-negative bacteria, anaerobic bacteria and microorganisms, such as Chlamydia trachomatis and Chlamydia pneumonia, Mycoplasma pneumonia and Borrelia burgdorferi, Treponema pallidum and Ureaplsma ureolyticum. Azithromycin is not active against Gram-positive bacteria resistant to erythromycin. Azithromycin belongs to the group of antibacterial drugs.
